Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous peramivir for complicated influenza
ACTRN12607000282482Phase 2Not yet recruiting
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised trial of peramivir in influenza (3 arms), sponsored by BioCryst Pharmaceuticals, Inc. Primary endpoint: Time to clinical stability. Planned start Jun 2007; status: not yet recruiting.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12607000282482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000282482.